The molecular biology of pituitary tumors: A personal perspective

Pituitary

Volumn 12, Issue 3, 2009, Pages 265-270

  Grossman, Ashley B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Genemutations; Sporadic pituitary tumor

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BRG1 PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IALPHA; GLUCOCORTICOID; HEAT SHOCK PROTEIN 90; HISTONE DEACETYLASE 2; KI 67 ANTIGEN; PROTEIN P27; PROTEIN TYROSINE KINASE INHIBITOR; SECURIN; VASOPRESSIN V1B RECEPTOR;

ACROMEGALY; ACTH SECRETING CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHROMOSOME 11Q; CUSHING DISEASE; DOWN REGULATION; GENE ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GONADOTROPIN SECRETING CELL; GROWTH HORMONE SECRETING CELL; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOPHYSIS TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TSH SECRETING CELL; UPREGULATION;

ANIMALS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PITUITARY NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 67849126387     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0158-7     Document Type: Article

References (37)

1. Spada A, Arosio M, Bochicchio D, Bazzoni N, Vallar L, Bassetti M et al (1990) Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71(6):1421-1426
2. Lania A, Mantovani G, Spada A (2003) Genetics of pituitary tumors: Focus on G-protein mutations. Exp Biol Med (Maywood) 228(9):1004-1017
3. Farrell WE, Simpson DJ, Bicknell J, Magnay JL, Kyrodimou E, Thakker RV et al (1999) Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours. Br J Cancer 80(1-2):44-50. doi: 10.1038/sj.bjc.6690319
4. Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T et al (2007) Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92(8):3321-3325. doi: 10.1210/ jc.2006-2843
5. Dahia PL, Aguiar RC, Honegger J, Fahlbush R, Jordan S, Lowe DG et al (1998) Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Oncogene 16(1):69-76. doi: 10.1038/ sj.onc.1201516
6. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, Swords FM et al (2002) Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin Endocrinol (Oxf) 57(4):443-448. doi: 10.1046/j.1365-2265.2002.01643.x
7. Sandrini F, Kirschner LS, Bei T, Farmakidis C, Yasufuku-Takano J, Takano K et al (2002) PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. J Med Genet 39(12):e78. doi: 10.1136/jmg.39.12.e78
8. Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD, Frohman LA (2000) Isolated familial somatotropinomas: Establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab 85(2):707-714. doi: 10.1210/ jc.85.2.707
9. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A et al (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312(5777):1228-1230. doi: 10.1126/ science.1126100
10. Marlowe JL, Puga A (2005) Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96(6):1174-1184. doi: 10.1002/jcb.20656
11. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S et al (2008) The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93(6):2390-2401. doi: 10.1210/jc.2007-2611
12. Iwata T, Yamada S, Mizusawa N, Golam HM, Sano T, Yoshimoto K (2007) The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clin Endocrinol (Oxf) 66(4):499-502
13. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA et al (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: Analysis in 73 families. J Clin Endocrinol Metab 92(5):1891-1896. doi: 10.1210/ jc.2006-2513
14. Toledo RA, Lourenco DM Jr, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB et al (2007) Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. J Clin Endocrinol Metab 92(5):1934-1937. doi: 10.1210/jc.2006-2394
15. Dahia PL, Ahmed-Shuaib A, Jacobs RA, Chew SL, Honegger J, Fahlbusch R et al (1996) Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. J Clin Endocrinol Metab 81(5):1768-1771. doi: 10.1210/jc.81.5.1768
16. Dahia PL, Honegger J, Reincke M, Jacobs RA, Mirtella A, Fahlbusch R et al (1997) Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. J Clin Endocrinol Metab 82(4):1088-1093. doi: 10.1210/jc.82.4.1088
17. Morris DG, Kola B, Borboli N, Kaltsas GA, Gueorguiev M, McNicol AM et al (2003) Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas. J Clin Endocrinol Metab 88(12):6080-6087. doi: 10.1210/jc.2002-022048
18. Korbonits M, Bujalska I, Shimojo M, Nobes J, Jordan S, Grossman AB et al (2001) Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: Induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. J Clin Endocrinol Metab 86(6):2728-2733. doi: 10.1210/jc.86.6.2728
19. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F et al (2006) Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev 20(20):2871-2886. doi: 10.1101/gad.1444606
20. Kola B, Korbonits M, Diaz-Cano S, Kaltsas G, Morris DG, Jordan S et al (2003) Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. Clin Endocrinol (Oxf) 59(3):328-338. doi: 10.1046/j.1365-2265.2003.01851.x
21. Asa SL, Digiovanni R, Jiang J, Ward ML, Loesch K, Yamada S et al (2007) A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. Cancer Res 67(15):7505-7511. doi: 10.1158/ 0008-5472.CAN-07-0219
22. Greenman Y, Prager D, Melmed S (1995) The IGF-I receptor sub-membrane domain is intact in GH-secreting pituitary tumours. Clin Endocrinol (Oxf) 42(2):169-172. doi: 10.1111/j.1365-2265.1995.tb01858.x
23. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X et al (1999) Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J Clin Endocrinol Metab 84(10):3823-3830. doi: 10.1210/jc.84.10.3823
24. Jin L, Qian X, Kulig E, Sanno N, Scheithauer BW, Kovacs K et al (1997) Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 151(2):509-519
25. Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z et al (2002) Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab 87(6):2635-2643. doi: 10.1210/jc.87.6.2635
26. Musat M, Korbonits M, Kola B, Borboli N, Hanson MR, Nanzer AM et al (2005) Enhanced protein kinase B/Akt signalling in pituitary tumours. Endocr Relat Cancer 12(2):423-433. doi: 10.1677/erc.1.00949
27. Farrell WE, Clayton RN (2003) Epigenetic change in pituitary tumorigenesis. Endocr Relat Cancer 10(2):323-330. doi: 10.1677/ erc.0.0100323
28. Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K et al (2007) Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res 67(21):10564-10572. doi: 10.1158/ 0008-5472.CAN-07-0974
29. Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B et al (2008) Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 93(10):4119-4125. doi: 10.1210/jc.2007-2633
30. Ewing I, Pedder-Smith S, Franchi G, Ruscica M, Emery M, Vax V et al (2007) A mutation and expression analysis of the oncogene BRAF in pituitary adenomas. Clin Endocrinol (Oxf) 66(3):348-352. doi: 10.1111/ j.1365-2265.2006.02735.x
31. Morris DG, Musat M, Czirjak S, Hanzely Z, Lillington DM, Korbonits M et al (2005) Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 153(1):143-151. doi: 10.1530/eje.1.01937
32. Dworakowska D et al (2008) Extracellular signal-regulated kinase (ERK 1/ 2) overactivation in pituitary adenomas. In: The endocrine society's annual meeting, San Francisco, USA
33. Vlotides G, Siegel E, Donangelo I, Gutman S, Ren SG, Melmed S (2008) Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands. Cancer Res 68(15):6377-6386. doi: 10.1158/0008-5472.CAN-08-0508
34. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD et al (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84(2):761-767. doi: 10.1210/ jc.84.2.761
35. Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G et al (2006) Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: A clinical and immunohistochemical study. Clin Endocrinol (Oxf) 65(4):536-543. doi: 10.1111/j.1365-2265.2006.02630.x
36. Abbud RA, Takumi I, Barker EM, Ren SG, Chen DY, Wawrowsky K et al (2005) Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol Endocrinol 19(5):1383-1391. doi: 10.1210/me.2004-0403
37. Vlotides G, Eigler T, Melmed S (2007) Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev 28(2):165-186. doi: 10.1210/er.2006-0042